120 likes | 131 Views
Learn about mucositis, a common condition affecting cancer patients undergoing treatment. Understand its epidemiology, symptoms, prognosis, and management approaches to improve patient comfort and outcomes.
E N D
The EPEC-O TM Education in Palliative and End-of-life Care - Oncology Project The EPEC-O Curriculum is produced by the EPECTM Project with major funding provided by NCI, with supplemental funding provided by the Lance Armstrong Foundation.
EPEC – Oncology Education in Palliative and End-of-life Care – Oncology Module 3o Symptoms – Mucositis
Mucositis . . . • Definition: mucosal barrier injury • It may affect the entire GI tract
. . . Mucositis Epidemiology. . . • Impact: • Oral erythema, ulceration, pain, infection • Diarrhea (if it affects entire GI tract) • Decreased oral intake • Raises 100-day mortality
. . . Mucositis . . . Epidemiology • Prevalence: • 40 % of patients on chemotherapy • 100 % if with stem cell transplant • Prognosis: • Usually self-limiting
Key points • Pathophysiology • Assessment • Management
Pathophysiology • Direct injury • Secondary infection • Graft versus host disease Plevova P. Oral Oncol, 1999.
Usual course • Starts 5 - 7 days after chemotherapy • Generalized desquamation days 11 - 14 • Resolution • 2 days to 2 – 3 weeks • 6 weeks after radiation Wilkes JD. Semin Oncol, 1998.
Assessment • History • Pain and its effect on the patient • Eating and drinking • Physical examination • Orthostatic blood pressure and pulse • Weight • Evaluate affected oral mucosa
Management . . . Potential for prevention • Diminish mucosal delivery, eg, oral cryotherapy • Modify epithelial proliferation, eg, growth factors • Reduce infections, inflammatory complications • Reduce, inhibit pro-inflammatory cytokines
. . . Management • Oral hygiene • Diet (minimize contact with food) • Local anesthetics • Systemic analgesics
Summary Use comprehensive assessment and pathophysiology-based therapy to treat the cause and improve the cancer experience